ErbB3 Monoclonal / Vio Bright FITC / REA508
ErbB3 Monoclonal / Vio Bright FITC / REA508
Citations:
(3)
Product Details
Supplier | Miltenyi Biotec | |
---|---|---|
Catalog #: | 130-107-903 (View supplier product page) | |
Size | 100 Tests in 1 ml | |
Price | $395.00 | |
Antigen | ErbB3 | |
Clone | REA508 | |
Host | Human | |
Isotype | IgG1 | |
Conjugate | Vio Bright FITC | |
Target Species | Human | |
Applications | FC | |
Description | Clone REA508 recognizes the human ErbB-3 antigen, a single-pass type I membrane protein, which is also known as tyrosine kinase-type cell surface receptor HER3. ErbB-3 is a receptor tyrosine kinase and a member of the epidermal growth factor receptor family (EGFR). It is unique among the ErbB family members in that it is has been shown to have weak or no tyrosine kinase activity. After dimerization with other members of the EGFR family several signal transduction cascades can be activated, including phosphoinosite 3'-kinase (PI3-K)/Akt and extracellular signal-regulated kinase (ERK1/2). ErbB-3 is widely expressed in normal tissues including cells of the gastrointestinal, reproductive, respiratory and urinary tracts, as well as the skin, endocrine, and nervous system. It is expressed at elevated levels in a range of human malignancies. | Additional information: Clone REA508 displays negligible binding to Fc receptors. |
About ErbB3 and Vio Bright FITC
ErbB3 | This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized. [provided by RefSeq, Jul 2008] | |
---|---|---|
Vio Bright FITC | Vio®Bright FITC has an excitation peak at 496 nm and an emission peak at 522 nm. It is recommended for use in flow cytometry and fluorescence microscopy. |
Citations
PMID 2687875 | ||
---|---|---|
PMID 12648465 | ||
PMID 25133484 | ||
Additional Sources |
Reviews & Ratings
Vio Bright FITC Excitation and Emission Spectra
$395.00
Supplier Page
Supplier Page